Legacy Capital Group California’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,228
Closed -$430K 306
2025
Q4
$430K Buy
1,228
+11
+0.9% +$3.72K 0.1% 234
2025
Q3
$393K Buy
1,217
+468
+62% +$146K 0.1% 243
2025
Q2
$291K Sell
749
-3
-0.4% -$1.21K 0.08% 270
2025
Q1
$327K Sell
752
-4
-0.5% -$1.61K 0.11% 213
2024
Q4
$279K Buy
756
+206
+37% +$86.2K 0.09% 255
2024
Q3
$286K Sell
550
-29
-5% -$15.5K 0.1% 241
2024
Q2
$314K Sell
579
-243
-30% -$128K 0.11% 214
2024
Q1
$426K Sell
822
-10
-1% -$4.97K 0.16% 184
2023
Q4
$392K Hold
832
0.15% 194
2023
Q3
$362K Sell
832
-7
-0.8% -$3.17K 0.16% 182
2023
Q2
$373K Buy
839
+25
+3% +$11.5K 0.15% 188
2023
Q1
$374K Buy
+814
New +$387K 0.18% 167

Other funds holding ELV

Legacy Capital Group California's ELV Position: Q1 2026 in Review

Legacy Capital Group California sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,228 shares — an estimated $430K sold.

Legacy Capital Group California first reported a position in ELV in Q1 2023 and held it in 12 quarters. The position peaked at $430K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Legacy Capital Group California reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Legacy Capital Group California sold 1,228 Elevance Health shares in Q1 2026, an estimated $430K.
  • Legacy Capital Group California first reported a position in Elevance Health in Q1 2023 and held it in 12 quarters.
  • Legacy Capital Group California's Elevance Health position peaked at $430K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Legacy Capital Group California's 13F filing for Q1 2026, filed 4 May 2026.